These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 27712761

  • 21. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S, Yilmaz I, Celik G, Aydin O, Erkekol FÖ, Orman A, Kurt E, Ediger D, Dursun B, Abadoğlu O, Ozşeker F, Akkaya E, Karakiş GP, Canbakan S, Yüksel S, Misirligil Z.
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [Abstract] [Full Text] [Related]

  • 22. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.
    White A, Bigby T, Stevenson D.
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):190-5. PubMed ID: 16937750
    [Abstract] [Full Text] [Related]

  • 23. Aspirin-exacerbated respiratory disease: burden of disease.
    Chang JE, White A, Simon RA, Stevenson DD.
    Allergy Asthma Proc; 2012 Aug; 33(2):117-21. PubMed ID: 22525387
    [Abstract] [Full Text] [Related]

  • 24. State of the Art: Medical treatment of aspirin exacerbated respiratory disease (AERD).
    Ta V, Simon R.
    Am J Rhinol Allergy; 2015 Aug; 29(1):41-3. PubMed ID: 25590318
    [Abstract] [Full Text] [Related]

  • 25. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
    Woessner KM, Simon RA, Stevenson DD.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
    [Abstract] [Full Text] [Related]

  • 26. Clinical updates in aspirin-exacerbated respiratory disease.
    Laidlaw TM.
    Allergy Asthma Proc; 2019 Jan 01; 40(1):4-6. PubMed ID: 30582489
    [Abstract] [Full Text] [Related]

  • 27. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y, Youssef S, Ahmed I, El Gaafary M.
    Ann Allergy Asthma Immunol; 2006 Jul 01; 97(1):105-9. PubMed ID: 16892790
    [Abstract] [Full Text] [Related]

  • 28. Aspirin Exacerbated Respiratory Disease.
    Fruth K, Gosepath J.
    Adv Otorhinolaryngol; 2016 Jul 01; 79():21-8. PubMed ID: 27466843
    [Abstract] [Full Text] [Related]

  • 29. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
    Simon RA, Dazy KM, Waldram JD.
    Curr Allergy Asthma Rep; 2015 Mar 01; 15(3):508. PubMed ID: 25663486
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data.
    Adame MJ, Raji M, Shan Y, Zhang Y, Kuo YF, Tripple JW.
    J Allergy Clin Immunol Pract; 2023 Nov 01; 11(11):3445-3453.e6. PubMed ID: 37468040
    [Abstract] [Full Text] [Related]

  • 33. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR, Ayars AG, Altman MC, Henderson WR.
    Immunol Allergy Clin North Am; 2016 Nov 01; 36(4):749-763. PubMed ID: 27712768
    [Abstract] [Full Text] [Related]

  • 34. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
    Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczyńska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wöhrl S, Dahlén B, Szczeklik A.
    Allergy; 2007 Oct 01; 62(10):1111-8. PubMed ID: 17521312
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.
    Ledford DK, Lockey RF.
    J Allergy Clin Immunol Pract; 2016 Oct 01; 4(4):590-8. PubMed ID: 27393773
    [Abstract] [Full Text] [Related]

  • 38. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK, Jerschow E, Divekar RD.
    Otolaryngol Clin North Am; 2024 Apr 01; 57(2):265-278. PubMed ID: 37833102
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.